The American College of Cardiology (ACC) has established the PINNACLE Registry Research Alliance to connect cardiovascular care teams with information about clinical trials and accelerate the systematic access of patients to potentially groundbreaking therapies.

Endologix Inc. announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial to evaluate the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System (EVAS).

st. jude portico transcatheter aortic heart valve repair hybrid or

St. Jude Medical Inc. received European CE mark approval for its 25-mm Portico Transcatheter Aortic Heart Valve Implantation System.

Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will evaluate the Symplicity renal denervation system in patients with moderate uncontrolled hypertension.

An investigational, manmade blood vessel used in vascular grafts for kidney dialysis patients may potentially show encouraging early results among study patients in Poland, according to preliminary data reported by a researcher at Duke Medicine.

Massachusetts was on the same brink in 2006 that the entire nation is on today: the brink of expanding health insurance to cover far more people than before through government-driven, market-based reform. 

 A study published in the Journal of the American Heart Association revealed findings that may impact diagnostic strategies and clinical decision-making for patients with suspected coronary artery disease (CAD).

To the gratification of the Healthcare Information and Management Systems Society (HIMSS), the U.S. Department of Health and Human Services, the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health IT have heard concerns from health stakeholders and extended Meaningful Use Stage 2 by one year.

Boston scientific autogen x4 crt-d crt ICD heart failure cardiac

Boston Scientific Corp. has received CE mark approval of its X4 line of quadripolar cardiac resynchronization therapy defibrillator (CRT-D) systems, including the AutoGen X4, DynaGen X4 and InoGen X4 CRT-Ds, a suite of Acuity X4 quadripolar LV leads and the Acuity Pro lead delivery system.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now